Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.03B | $4.24B | $3.71B | $3.03B | $2.63B | $2.39B | $2.04B | $1.75B | $1.60B | $1.65B | — | — | — | — | — | — | — |
| Operating income | $425.3M | $358.3M | $255.4M | $296.8M | $260.5M | $223.2M | $129.2M | $84.9M | $43.2M | $91.8M | $93.1M | $72.9M | $57.9M | $78.3M | $90.7M | $75.7M | $58.9M |
| EBITDAderived | $529.6M | $442.4M | $327.8M | $359.2M | $316.4M | $277.7M | $180.2M | $129.8M | $85.5M | $130.5M | $121.2M | $99.4M | $91.9M | $106.6M | $114.0M | $92.3M | $72.2M |
| Net income | $344.0M | $298.0M | $209.4M | $224.7M | $194.7M | $170.5M | $110.5M | $92.4M | $40.5M | $50.0M | $55.4M | $36.0M | $24.0M | $40.6M | $47.7M | $40.5M | $32.5M |
| Basic EPSper diluted share | $6.00 | $5.26 | $3.76 | $4.09 | $3.57 | $3.19 | $2.07 | $1.78 | $0.79 | $0.99 | $1.10 | $0.80 | $0.55 | $1.89 | $2.27 | $1.95 | $1.58 |
| Diluted EPSper diluted share | $5.84 | $5.12 | $3.65 | $3.95 | $3.42 | $3.06 | $1.97 | $1.70 | $0.77 | $0.96 | $1.06 | $0.78 | $0.54 | $1.85 | $2.21 | $1.92 | $1.55 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 2, 2026Form 4 · 10b5-1 | SMITH BARRY MDirector | SellCommon Stock | 700 | $164.28 | $115.0K | 21.4K |
| May 4, 2026Form 4 · 10b5-1 | SMITH BARRY MDirector | SellCommon Stock | 700 | $182.21 | $127.5K | 22.1K |
| Apr 20, 2026Form 4 · 10b5-1 | Agwunobi John ODirector | SellCommon Stock | 392 | $199.97 | $78.4K | 9.3K |
| Apr 16, 2026Form 4 · 10b5-1 | Parkinson Mark VincentDirector | SellCommon Stock | 100 | $196.60 | $19.7K | 3.4K |
| Apr 2, 2026Form 4 · 10b5-1 | SMITH BARRY MDirector | SellCommon Stock | 700 | $196.65 | $137.7K | 22.2K |